`______________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`APOTEX INC., APOTEX CORP., and
`ARGENTUM PHARMACEUTICALS LLC,
`Petitioners,
` v.
`NOVARTIS AG,
`Patent Owner.
`______________________
`Case IPR2017-008541
`U.S. Patent No. 9,187,405
`______________________
`PATENT OWNER’S UPDATED MANDATORY NOTICE
`
`
`Mail Stop Patent Board
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
` 1 Case IPR2017-01550 has been joined with this proceeding.
`
`
`
`
`
`Case No. IPR2017-00584
`Patent No. 9,187,504
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner submits the following update to
`
`its Mandatory Notice. The below change to the real parties-in-interest occurred on
`
`August 16, 2017. Patent Owner therefore submits this update within the 21 days
`
`allowed by 37 C.F.R. § 42.8(a)(3).
`
`1.
`
`Real Parties-In-Interest (37 C.F.R. § 42.8(b)(1))
`
`Novartis AG has assigned its rights in U.S. Patent 9,187,405 to Novartis
`
`Pharmaceuticals Corporation (see Assignment at Reel 043314/Frame 0800). The
`
`real party in interest is Novartis Pharmaceuticals Corporation. Novartis AG and
`
`other Novartis subsidiaries may also have an interest.
`
`
`
`Dated: September 5, 2017
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`
`Lead Counsel for Patent Owner
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, New York 10166-0193
`jlove@gibsondunn.com
`Tel: 212-351-3922
`
`
`
`
`1
`
`
`
`Case No. IPR2017-00854
`Patent No. 9,187,405
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), I hereby certify that on September 5, 2017, a
`
`true and accurate copy of PATENT OWNER’S UPDATED MANDATORY
`
`NOTICE was served via electronic mail, by agreement of the parties, on the
`
`following counsel of record for Petitioners:
`
`For Apotex:
`
`For Argentum:
`
`
`Steven W. Parmelee: sparmelee@wsgr.com
`Michael T. Rosato: mrosato@wsgr.com
`Jad. A. Mills: jmills@wsgr.com
`
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`Telephone: 206-883-2542
`
`
`
`Teresa Stanek Rea: trea@crowell.com
`Deborah H. Yellin: dyellin@crowell.com
`Shannon M. Lentz: slentz@crowell.com
`Tyler C. Liu: TLiu@agpharm.com
`
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`Washington, DC 20004-2595
`(202) 624-2620
`
`
`
`Dated: September 5, 2017
`
`/Jane M. Love, Ph.D./
`Jane M. Love, Ph.D.
`Reg. No. 42,812
`
`
`
`
`
`2
`
`
`
`
`
`Case No. IPR2017-00584
`Patent No. 9,187,504
`
`Lead Counsel for Patent Owners
`Gibson, Dunn & Crutcher LLP
`200 Park Avenue
`New York, New York 10166-0193
`jlove@gibsondunn.com
`Tel: 212-351-3922
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`